Product Information
TOPIRAMATE ER 150 MG SPRINK CAP is a generic product labeled by Vitruvias Therapeutics Inc., priced at $8.8317 per EA under NDC 69680018030. Its NADAC has been published 51 times since Jul 9, 2025.
Strength
150 mg/1
Manufacturer
Vitruvias Therapeutics Inc.NDC
69680018030
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA215638On Market Since
4/7/2025
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE ER 150 MG SPRINK CAP has been published 51 times since Jul 9, 2025, and over the history we have for it it has declined 29.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.8317 per EA |
|---|---|
| All-time high | $12.4622 (Jul 16, 2025) |
| All-time low | $8.8317 (Jun 17, 2026) |
| 52-week high | $12.4622 |
| 52-week low | $8.8317 |
| Median price | $11.1041 |
| Average price | $11.2395 |
| Largest weekly change | -13.2% (Jun 17, 2026) |
| Weeks tracked | 51 |
| Tracking since | Jul 9, 2025 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TOPIRAMATE ER 150 MG SPRINK CAP?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 150 MG SPRINK CAP, manufactured by Vitruvias Therapeutics Inc., is $8.8317 per EA (NDC 69680018030), effective Jun 24, 2026.
How has the price of TOPIRAMATE ER 150 MG SPRINK CAP changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE ER 150 MG SPRINK CAP has declined 29.1%. It has been tracked across 51 weekly CMS publications since Jul 9, 2025.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 150 MG SPRINK CAP?
Since Jul 9, 2025, the NADAC for TOPIRAMATE ER 150 MG SPRINK CAP has ranged from a low of $8.8317 (Jun 17, 2026) to a high of $12.4622 (Jul 16, 2025), with a median of $11.1041 per EA.
Are there cheaper alternatives to TOPIRAMATE ER 150 MG SPRINK CAP?
2 NADAC-published products share the same active ingredient, strength, and dosage form as TOPIRAMATE ER 150 MG SPRINK CAP, but none are currently priced below it.
Who manufactures TOPIRAMATE ER 150 MG SPRINK CAP?
TOPIRAMATE ER 150 MG SPRINK CAP (NDC 69680018030) is labeled by Vitruvias Therapeutics Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification